RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Quest Diagnostics Stock

Quest Diagnostics Net Income 2024

Quest Diagnostics Net Income

1 B USD

Ticker

DGX

ISIN

US74834L1008

WKN

904533

In 2024, Quest Diagnostics's profit amounted to 1 B USD, a 18.09% increase from the 850 M USD profit recorded in the previous year.

The Quest Diagnostics Net Income history

YEARNET INCOME (undefined USD)
2028e1.34
2027e1.23
2026e1.2
2025e1.1
2024e1
20230.85
20220.94
20211.99
20201.43
20190.86
20180.73
20170.77
20160.64
20150.71
20140.55
20130.85
20120.55
20110.47
20100.72
20090.73
20080.58
20070.34
20060.59
20050.55
20040.5

Quest Diagnostics Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Quest Diagnostics, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Quest Diagnostics from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Quest Diagnostics’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Quest Diagnostics. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Quest Diagnostics’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Quest Diagnostics’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Quest Diagnostics’s growth potential.

Quest Diagnostics Revenue, EBIT and net profit per share

DateQuest Diagnostics RevenueQuest Diagnostics EBITQuest Diagnostics Net Income
2028e10.52 B undefined1.88 B undefined1.34 B undefined
2027e10.26 B undefined1.78 B undefined1.23 B undefined
2026e11.2 B undefined1.79 B undefined1.2 B undefined
2025e10.79 B undefined1.67 B undefined1.1 B undefined
2024e9.93 B undefined1.52 B undefined1 B undefined
20239.25 B undefined1.32 B undefined850 M undefined
20229.88 B undefined1.52 B undefined942 M undefined
202110.79 B undefined2.5 B undefined1.99 B undefined
20209.44 B undefined1.99 B undefined1.43 B undefined
20197.73 B undefined1.32 B undefined855 M undefined
20187.53 B undefined1.23 B undefined733 M undefined
20177.4 B undefined1.27 B undefined769 M undefined
20167.52 B undefined1.24 B undefined642 M undefined
20157.49 B undefined1.1 B undefined706 M undefined
20147.44 B undefined1.03 B undefined554 M undefined
20137.15 B undefined1.12 B undefined846 M undefined
20127.38 B undefined1.32 B undefined553.2 M undefined
20117.39 B undefined1.3 B undefined467.7 M undefined
20107.26 B undefined1.32 B undefined717.6 M undefined
20097.46 B undefined1.35 B undefined726.9 M undefined
20087.25 B undefined1.22 B undefined580.2 M undefined
20076.7 B undefined1.09 B undefined339.9 M undefined
20066.27 B undefined1.13 B undefined586.4 M undefined
20055.46 B undefined1.01 B undefined546.3 M undefined
20045.07 B undefined880.9 M undefined499.2 M undefined

Quest Diagnostics stock margins

The Quest Diagnostics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Quest Diagnostics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Quest Diagnostics.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Quest Diagnostics's sales revenue. A higher gross margin percentage indicates that the Quest Diagnostics retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Quest Diagnostics's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Quest Diagnostics's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Quest Diagnostics's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Quest Diagnostics. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Quest Diagnostics's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Quest Diagnostics Margin History

Quest Diagnostics Gross marginQuest Diagnostics Profit marginQuest Diagnostics EBIT marginQuest Diagnostics Profit margin
2028e33.14 %17.89 %12.72 %
2027e33.14 %17.37 %12.02 %
2026e33.14 %15.95 %10.72 %
2025e33.14 %15.45 %10.19 %
2024e33.14 %15.28 %10.11 %
202333.14 %14.22 %9.19 %
202235.06 %15.38 %9.53 %
202139.66 %23.15 %18.43 %
202038.18 %21.1 %15.1 %
201935.26 %17.1 %11.07 %
201835.33 %16.29 %9.73 %
201736.85 %17.16 %10.39 %
201639.11 %16.45 %8.54 %
201538.28 %14.73 %9.42 %
201437.92 %13.81 %7.45 %
201339.84 %15.63 %11.84 %
201241.58 %17.86 %7.49 %
201141.27 %17.57 %6.33 %
201041.2 %18.2 %9.88 %
200942.04 %18.05 %9.75 %
200841.29 %16.86 %8 %
200740.79 %16.28 %5.07 %
200641.04 %18 %9.35 %
200540.98 %18.46 %10.01 %
200441.39 %17.39 %9.85 %

Quest Diagnostics Aktienanalyse

What does Quest Diagnostics do?

Quest Diagnostics Inc is a leading company in the field of diagnostic information and services, headquartered in New Jersey, USA. The company is dedicated to providing medical professionals and patients worldwide with fast, accurate, and preventive diagnostic tests. The history of Quest Diagnostics dates back to 1967 when the company MetPath was founded by Dr. Paul A. Brown. In the following years, several acquisitions and mergers took place, eventually leading to the establishment of Quest Diagnostics in 1996. Since then, the company has continuously evolved and now offers a wide range of diagnostic tests and services, ranging from the analysis of blood samples to genetic testing procedures. The business model of Quest Diagnostics is based on providing high-quality and individualized information to medical professionals and patients to assist in the diagnosis, treatment, and cure of their health problems. The company works closely with doctors, hospitals, and other medical institutions worldwide to offer a comprehensive range of innovative diagnostic products, procedures, and technologies tailored to meet specific needs. Quest Diagnostics offers a wide range of services, ranging from laboratory testing to data management and clinical trials. The company has various business segments, including the Diagnostic Services business, the Medical Research Services business, and the Information Services business. In the field of Diagnostic Services, Quest Diagnostics offers a broad spectrum of laboratory tests divided into different categories such as cancer diagnostics, cardiology, endocrinology, immunology, and infectious diseases. The company also provides a variety of genetic tests that enable precise analysis of individual genomes, supporting the diagnosis and treatment of various genetic disorders. In the medical research field, Quest Diagnostics provides a range of services to support clinical trials and drug development. The company also offers a wide range of laboratory tests used in biomedical research to improve people's health and well-being. The Information Services business segment of Quest Diagnostics mainly focuses on providing innovative solutions in the field of data management and information technology. This includes the development of software tools that can be used for the analysis and management of health data. Additionally, the company offers consulting services to help medical professionals address challenges related to information processing and data integration. Quest Diagnostics is a company based on innovation and knowledge that collaborates closely with doctors, clinics, and other medical facilities worldwide to offer a relatively comprehensive range of need-specific diagnostic products, procedures, and solutions. From cancer diagnostics to genomic diagnostics, from clinical trials to information and data services, and a wide range of molecular diagnostic tests and laboratory analyses, Quest Diagnostics provides top-notch solutions for optimal patient care, contributing to the goal of improving global healthcare for people worldwide. Quest Diagnostics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Quest Diagnostics's Profit Margins

The profit margins of Quest Diagnostics represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Quest Diagnostics's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Quest Diagnostics's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Quest Diagnostics's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Quest Diagnostics’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Quest Diagnostics stock

How much profit has Quest Diagnostics made this year?

Quest Diagnostics has made 1 B USD this year.

How has the profit developed compared to last year?

The profit has increased by 18.09% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Quest Diagnostics publish its earnings?

Quest Diagnostics publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Quest Diagnostics?

The profits of Quest Diagnostics are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Quest Diagnostics?

You can learn more about the earnings of Quest Diagnostics by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Quest Diagnostics pay?

Over the past 12 months, Quest Diagnostics paid a dividend of 2.79 USD . This corresponds to a dividend yield of about 1.8 %. For the coming 12 months, Quest Diagnostics is expected to pay a dividend of 3.12 USD.

What is the dividend yield of Quest Diagnostics?

The current dividend yield of Quest Diagnostics is 1.8 %.

When does Quest Diagnostics pay dividends?

Quest Diagnostics pays a quarterly dividend. This is distributed in the months of February, May, August, November.

How secure is the dividend of Quest Diagnostics?

Quest Diagnostics paid dividends every year for the past 25 years.

What is the dividend of Quest Diagnostics?

For the upcoming 12 months, dividends amounting to 3.12 USD are expected. This corresponds to a dividend yield of 2.01 %.

In which sector is Quest Diagnostics located?

Quest Diagnostics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Quest Diagnostics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Quest Diagnostics from 10/21/2024 amounting to 0.75 USD, you needed to have the stock in your portfolio before the ex-date on 10/4/2024.

When did Quest Diagnostics pay the last dividend?

The last dividend was paid out on 10/21/2024.

What was the dividend of Quest Diagnostics in the year 2023?

In the year 2023, Quest Diagnostics distributed 2.6 USD as dividends.

In which currency does Quest Diagnostics pay out the dividend?

The dividends of Quest Diagnostics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Quest Diagnostics

Our stock analysis for Quest Diagnostics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Quest Diagnostics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.